ML202
ML202 is a highly specific allosteric activator of human pyruvate kinase M2 (hPK-M2), which can affect the cooperativity of phosphoenolpyruvate (PEP) binding, while adenosine diphosphate (ADP) binding almost no effect[1].
Product Specifications
CAS Number
1221186-52-2
UNSPSC
12352005
Target
Pyruvate Kinase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ml202.html
Purity
99.27
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1C2=C(C3=C(N2C)C=C(S(C)=O)S3)C=NN1CC4=CC(OC)=CC=C4
Molecular Formula
C18H17N3O3S2
Molecular Weight
387.48
References & Citations
[1]Matthew B Boxer, et al. Identification of activators for the M2 isoform of human pyruvate kinase Version 3. 2009 Sep 1 [updated 2011 Mar 3]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD) : National Center for Biotechnology Information (US) ; 2010–.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1893-75 5 mg
KN-62 (1- (N, O-Bis-[5-isoquinolinesulfonyl]-N-methyl-L-tyrosyl) -4-phenylpiperazine, (S) -5-Isoquinolinesulfonic Acid 4- (2-[ (5-Isoquinolinylsulfonyl) methylamino]- 3-oxo-3-[4-phenyl-1-piperazinyl]propyl) phenyl Ester, )
Sign In for Pricing
View Details 
MBS6319047-01 0.2 mL
MARK1, CT (MARK1, KIAA1477, MARK, Serine/threonine-protein kinase MARK1, MAP/microtubule affinity-regulating kinase 1, PAR1 homolog c) (Biotin)
Sign In for Pricing
View Details MBS6319047-02 5x 0.2 mL
MARK1, CT (MARK1, KIAA1477, MARK, Serine/threonine-protein kinase MARK1, MAP/microtubule affinity-regulating kinase 1, PAR1 homolog c) (Biotin)
Sign In for Pricing
View Details